Radiofrequency ablation for the treatment of colorectal liver metastases (IPG327)
Fast, easy summary view of NICE guidance on 'colorectal cancer'
The National Institute for Health and Clinical Excellence (NICE) has issued full guidance to the NHS in England, Wales, Scotland and Northern Ireland on Radiofrequency ablation for the treatment of colorectal liver metastases.
It replaces the previous guidance on Radiofrequency ablation for the treatment of colorectal metastases in the liver (Interventional Procedures Guidance no. 92, September 2004).
Colorectal cancer is a type of cancer that develops in the bowel (including the colon and rectum). In some patients, cancer cells could spread from the bowel to other parts of the body to form one or more ‘secondary tumours’, also known as ‘metastases’. For bowel cancer, most commonly secondary tumours occur in the liver.
Radiofrequency ablation uses heat to destroy cancer cells in the liver. It involves placing one or more electrodes into the tumour. The electrodes are used to heat the tumour with the aim of destroying it. Radiofrequency ablation can be applied through the skin or during surgery.
J12.4 Percutaneous radiofrequency ablation of lesion of liver
Y53.- Approach to organ under image control
Note: Codes within category Y53.- are used as secondary codes to classify interventions that are percutaneous and require some form of image control: if the method of image control is unspecified, Y53.9 Unspecified approach to organ under image control is assigned.
In addition the ICD-10 code C78.7 Secondary malignant neoplasm of liver and intrahepatic bile duct and a code from category C18.- Malignant neoplasm of colon would be recorded.
The NHS Classifications Service of NHS Connecting for Health is the central definitive source for clinical coding guidance and determines the coding standards associated with the classifications (OPCS-4 and ICD-10) to be used across the NHS. The NHS Classifications Service and NICE work collaboratively to ensure the most appropriate classification codes are provided. www.connectingforhealth.co.uk/clinicalcoding
- IPG327 Radiofrequency ablation for the treatment of colorectal liver metastases: full guidance (web format)
- Radiofrequency ablation for the treatment of colorectal metastases in the liver (interventional procedures consultation)
- Radiofrequency ablation for the treatment of colorectal metastases in the liver (interventional procedures overview)
- IPG327 Radiofrequency ablation for the treatment of colorectal liver metastases: consultation comments table
- Interventional procedure consultation document - radiofrequency ablation for the treatment of colorectal metastases in the liver
This guidance has been incorporated into the following NICE Pathways, along with other related guidance and products.
Visit the NICE Pathway: colorectal cancer
This page was last updated: 15 June 2012
- Web format
- Full Guidance (PDF)
- IPG327 Abladiad radioamledd i drin metastasisau'r colon a'r rhefr yn yr afu/iau: deall canllawiau NICE (fformat MS Word)
Information for the public
Implementation tools and resources
- None available
The summary of the key recommendations in the guidance written for patients, carers and those with little medical knowledge and may be used in local patient information leaflets.
Quick Reference Guide
The quick reference guide presents recommendations for health professionals
The published NICE clinical guidance, contains the recommendations for health professionals and NHS bodies.
The published full clinical guidance for specialists with background, evidence, recommendations and methods used.